Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00181558
What this trial is testing

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Massachusetts General Hospital 44
Large-scale testing (Phase 3)Study completedNCT00330759
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Who this might be right for
Bone Metastases
Amgen 1,779
Large-scale testing (Phase 3)Not Yet RecruitingNCT07725523
What this trial is testing

Safety and Efficacy of OTL78 (Zopocianine)

Who this might be right for
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler 36
Not applicableStudy completedNCT04021394
What this trial is testing

Influence of EMT on CTCs and Disease Progression in Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 31
Early research (Phase 1)Active Not RecruitingNCT07214961
What this trial is testing

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer (CRPC)Metastatic Castrate Resistant Prostate Cancer (mCRPC)
ARTBIO Inc. 80
Early research (Phase 1)Ended earlyNCT04931823
What this trial is testing

Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Conjupro Biotherapeutics, Inc. 34
Testing effectiveness (Phase 2)Study completedNCT02903160
What this trial is testing

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Study completedNCT06849544
What this trial is testing

Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Who this might be right for
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler 22
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Not applicableStudy completedNCT03927287
What this trial is testing

Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

Who this might be right for
MetastasisCastration-resistant Prostate CancerDeath
Rabin Medical Center 822
Not applicableLooking for participantsNCT04983095
What this trial is testing

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticRadiation TherapyPositron-Emission Tomography
Karin Soderkvist 118
Not applicableLooking for participantsNCT06046131
What this trial is testing

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Who this might be right for
Prostatic NeoplasmAdenocarcinomaNeoplasm Recurrence+1 more
Centre Hospitalier Universitaire de la Guadeloupe 3,000
Large-scale testing (Phase 3)Study completedNCT00377156
What this trial is testing

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Breast CancerCognitive/Functional EffectsLung Cancer+2 more
Alliance for Clinical Trials in Oncology 213
Not applicableStudy completedNCT02803437
What this trial is testing

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 334
Not applicableLooking for participantsNCT06462963
What this trial is testing

OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)

Who this might be right for
Breast CancerProstate CancerNSCLC+2 more
European Organisation for Research and Treatment of Cancer - EORTC 302
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Not applicableLooking for participantsNCT04612907
What this trial is testing

Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate CancerRadiotherapy Side EffectMetastatic Cancer
Umeå University 420
Early research (Phase 1)Study completedNCT03388619
What this trial is testing

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Who this might be right for
Cancer Of ProstateProstate NeoplasmsProstate Cancer+2 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05404139
What this trial is testing

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 352
Early research (Phase 1)Study completedNCT00872157
What this trial is testing

BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 10
Next Page